ACTG Presents Important Findings from REPRIEVE at CROI 2025
To learn more, please visit www.reprievetrial.org.
Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...
MindSite News on MSN7d
COVID stole a parent from more than 200,000 children. Indian Country lost the most.
As the world marks the 5-year anniversary of the start of the COVID pandemic, grieving children still need support ...
Charlotte Observer6d
Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
These results were the subject of a December 11, 2024 poster presentation at the San ... relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company ...